Scinai Immunotherapeutics Ltd（SCNI）のニュースとイベントSCNIScinai Immunotherapeutics Ltd

Scinai Files to Sell 16.34M American Depositary Shares

Scinai files to sell 16.34M American Depositary shares for holders

Scinai Immunotherapeutics Signs Securities Purchase Agreement, Raises Approximately $2.61M

Scinai Immunotherapeutics announced that it has entered into a securities purchase agreement with an institutional life sciences investor, as well as with new and existing institutional and accredited investors, for the purchase and sale of 5,208,333 American Depositary Shares, each representing 4,000 ordinary shares, at a purchase price of 48c per ADS, as well as a Series A warrant to purchase up to 5,208,333 ADSs at an exercise price of 48c per ADS, exercisable immediately with a term of two years, and a Series B warrant to purchase up to 5,208,333 ADSs at an exercise price of 55c per ADS, exercisable immediately with a term of five years. In addition, the company entered into a warrant inducement agreement with an existing institutional investor of the company for the immediate exercise of warrants to purchase up to 229,310 ADSs of its ordinary shares at an exercise price of 48c per ADS. The aggregate gross proceeds from the private placement and the warrant inducement transaction are approximately $2.61M, before deducting fees and expenses, and the closing of the transactions is expected to occur on or about April 27, subject to satisfaction of customary closing conditions. A.G.P./Alliance Global Partners acted as the sole financial advisor for the transactions.

Major Averages Rise as US-Iran Ceasefire Talks Emerge

The major averages closed broadly higher as investors weigh the odds that the U.S.-Iran war could potentially be over soon. On one hand, there are reported to be talks around a potential 45-day ceasefire between the U.S. and Iran, which has helped stabilize sentiment and even push oil lower at moments. On the other hand, renewed threats around striking Iranian infrastructure are keeping crude elevated around the $110 range and preventing a full risk-on move. Adding to tensions were comments by President Trump this afternoon that Iran "could be taken out in one night," and that night "might" be this Tuesday if Iran does not reach a deal with the U.S.Meanwhile, Monday was the first trading day since the U.S. Bureau of Labor Statistics announced its jobs report for March. The U.S. added 178,000 jobs last month, the biggest gain since December 2024, with the unemployment rate falling to 4.3%.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:NeurocrineSoleno Therapeuticsfor $53 per share in cashAn Italian court ruled that Netflixunlawfully increased prices,WWannounced the establishment of theOracleannounced the appointment of Hilary Maxson as CFO, which Barclays views as aMarch U.S. nonfarm payrolls rose 178,000, with the unemployment rate2. WALL STREET CALLS:Netflixto Buy at Goldman SachsCarvanato Neutral at BofAKratos Defenseto Buy at Jefferies on missile demandTwilioto Buy at JefferiesBofADow Inc.and LyondellBasellto Underperform3. AROUND THE WEB:Metawill launch AI models with an open source license, Axios reportsA Meta-backeddata center campus is seeking $3B in construction loans for an off-grid project, FT reportsLiberty Globalhas tabled an offer to buy a London-based franchise that would participate in a new European basketball league being set up by the National Basketball Association, Sky News saysParamounthas received signed equity commitments of close to $24B from three sovereign-wealth funds led by Saudi Arabia to help back its takeover of Warner Bros. Discovery, WSJ reportsUniversal Pictures'and Nintendo's"The Super Mario Galaxy Movie" has earned an estimated $372.5M in worldwide box-office sales, the biggest opening of 2026 so far, WSJ says4. MOVERS:FuboTVgains after providingand FY28AMC Entertainmentincreases after delivering aover the 5-day Easter weekendSeagatehigher after Morgan Stanley named theViridianfalls after Amgen'sPhase 3 trial of Tepezza met itsAtlas Energylower after announcing a5. EARNINGS/GUIDANCE:Sunshine Biopharma, with EPS and revenue higher year-over-yearScinai ImmunotherapeuticstargetedDeFi Technologies, with the company stating, "These results reflect the strength of the business model we have built"Delta Air Linesis expected toon April 8, 2026Constellation Brandsis expected toon April 8, 2026INDEXES:The Dow rose 165.21, or 0.36%, to 46,669.88, the Nasdaq gained 117.16, or 0.54%, to 21,996.34, and the S&P 500 advanced 29.14, or 0.44%, to 6,611.83.